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Rheumatoid arthritis (RA) is a chronic, systemic, autoimmune, inﬂammatory disease associated with cachexia (reduced muscle
and increased fat). Although strength-training exercise has been used in persons with RA, it is not clear if it is eﬀective for reducing
cachexia. A 46-year-old woman was studied to determine: (i) if resistance exercise could reverse cachexia by improving muscle
mass, ﬁber cross-sectional area, and muscle function; and (2) if elevated apoptotic signaling was involved in cachexia with RA
and could be reduced by resistance training. A needle biopsy was obtained from the vastus lateralis muscle of the RA subject
before and after 16 weeks of resistance training. Knee extensor strength increased by 13.6% and fatigue decreased by 2.8% Muscle
mass increased by 2.1%. Average muscle ﬁber cross-sectional area increased by 49.7%, and muscle nuclei increased slightly after
strength training from 0.08 to 0.12 nuclei/μm2. In addition, there was a slight decrease (1.6%) in the number of apoptotic muscle
nuclei after resistance training. This case study suggests that resistance training may be a good tool for increasing the number of
nuclei per ﬁber area, decreasing apoptotic nuclei, and inducing ﬁber hypertrophy in persons with RA, thereby slowing or reversing
rheumatoid cachexia.
1.Introduction
Rheumatoid arthritis (RA) is a chronic, systemic, autoim-
mune, inﬂammatory condition that is associated with a
reduced life expectancy [1, 2]. Patients with RA have re-
stricted range of motion of joints, joints pain and reduced
physical functioning, increased resting energy expenditure,
and higher mortality rate. In addition to the direct eﬀects
of RA on joints, this disease is characterized by a loss of
muscle mass (rheumatoid cachexia), an increase in fat mass,
and normal or high body mass index (BMI). More than 50%
of RA patients develop rheumatoid cachexia and as a result
lose muscle strength, and power, and reduce their levels of
physical activity [3].
Habitual physical activity is decreased in RA patients due
to joint pain, restricted mobility, fatigue, reduced muscle
mass, strength, and endurance, and these will result in
decreasedphysicalﬁtness.RA-inducedreductionsinphysical
activity can result in muscle loss, which further exacerbates
rheumatoid cachexia [4]. Furthermore, low physical activity
increases the risk for RA patients to develop cardiovascular
disease, osteoporosis, insulin resistance, and obesity [3].
Rheumatoid cachexia predominantly aﬀects type II ﬁ-
bers, although both ﬁber types are susceptible to atrophy2 Case Reports in Medicine
in RA [5]. Resistance exercise is a potential therapeutic
approach to improve muscle mass, especially in type II ﬁbers
[6]; however, there is little consensus in the literature to
support prescribing resistance or aerobic exercise in patients
with RA. While exercise-induced improvements in muscle
strength, physical function, and aerobic capacity have been
reported in patients with RA (reviewed in [7]), it is not clear
towhatextentaerobicorstrength(resistance)trainingmight
reduce rheumatoid cachexia, cardiovascular dysfunction,
and cardiovascular risk factors and/or improve the quality of
life of these patients.
The elevated production of cytokines (i.e., TNF-α and
IL-1β) contributes to rheumatoid cachexia. Cytokines are
among the important mechanisms that trigger cell death by
apoptosis in many diseases including rheumatoid arthritis
(reviewed in [8]). Apoptosis (nuclear apoptosis) is unique
in skeletal muscle, because death of a myonucleus via
apoptosis can occur without death of the entire cell. Nuclear
apoptosis has been reported during skeletal muscle loss that
is associated with aging, denervation, cardiovascular disease,
and cancer [9–11]. While apoptosis in skeletal muscle can
be triggered by cytokines [9], it is not known if nuclear
apoptosis also contributes to muscle loss in rheumatoid
cachexia. Furthermore, it is not clear if exercise might reduce
proapoptotic signaling and improve muscle function in
patientswithRA.Thisinformationiscriticalforunderstand-
ing the etiology of RA more completely and to determine
the potential eﬀects that exercise might have on rheumatoid
cachexia.Inthiscasestudy,weexaminetheeﬀectsofstrength
training on muscle structure and function, and nuclear
apoptosis in a subject with RA.
2.CaseReport
2.1. Subject Characteristics. A 46-year-old female was
recruited from the outpatient Rheumatology Clinic at Ruby
Memorial Hospital, Morgantown, WVa, USA. The subject
wasdiagnosedwithRAfor2yearsaccordingtotheguidelines
described by the American College of Rheumatology [12],
and she had history of seasonal asthma and gastritis. She
was treated with etanercept subcutaneously (50mg/week),
methotrexate (15mg/week), and etodolac (300mg/twice
daily). The subject gave written informed consent to partici-
pate in this study and to conduct strength training.
2.2. Assessments of Disease Progression. The subject under-
went a full physical examination and 12 lead ECG to rule
out overt cardiovascular disease or any contraindication to
strength training. Disease progression was assessed in 28
joints by the Disease Activity Score (DAS28) [13], and sys-
temic inﬂammation was estimated by erythrocyte sedimen-
tation rate (ESR) and fasting serum levels of C-reactive pro-
tein. Additional indices of general systemic cardiovascular
risk included blood levels of triglycerides, total cholesterol,
high-density lipoproteins (HDL), low- density lipoproteins
(LDL), and very-low-density lipoproteins (VLDL).
2.3. Physical Characteristics. The subject’s body mass index
(BMI) was calculated from height and weight measurements
that were made with the subject wearing a swimsuit and
without shoes using a calibrated electrical scale. Resting
energy expenditure (REE) was estimated using an open-
circuit ventilated hood system indirect calorimetric method
for 30min under thermoneutral conditions in the fasting
state (True Max 2400, ParvoMedics, Salt Lake City, Utah,
USA). Fat mass and percent body fat were measured by 7-
site skinfolds assessment, using a Harpenden skinfold caliper
(British indicators, UK). Each skinfold site was assessed a
minimum of two times. If measurements were not within
1mm, a third measure was taken. Fat-free mass (FFM) was
calculated as total bodyweight minus fat mass FM.
2.4. Functional and Cardiovascular Assessments. A 50-foot
walking test and a 30s maximal sit-to-stand test were
performed [14, 15]. Peak oxygen consumption (VO2peak)
were measured using indirect calorimetry (True Max 2400,
ParvoMedics, Salt Lake City, Utah,USA) during a graded
treadmill exercise test at 2.5m/h. The elevation of the tread-
mill was increased by one percent every minute. The graded
exercise test was continued until the subject could no longer
exercise. VO2peak was established if the following criteria
were met: (a) peak respiratory exchange ratio >1.10, (b)
attainment of at least 85% of maximal heart rate and (c)
ratings of perceived exertion (RPE) were 17 using the Borg
6–20 scale.
2.5. Muscle Function. Knee extensor and ﬂexor isokinetic
torque was assessed on the subject’s dominant limb. The
measurements were obtained before and 24 hours after
the subject’s last exercise session using methods previously
reported by our laboratory [14–16]. Torque was measured
onaBiodexSystem4dynamometer(BiodexInc.,Shirley ,NY ,
USA). Brieﬂy, the subject sat with the hip joint ﬂexed to 90◦.
Thesubject’strunkandpelvisweresecuredwithnylonstraps
topreventextraneousmovement.Torquewasrecordedasthe
best of ﬁve maximal voluntary contractions on the dominant
legwhilethesubjectwasseated,withvelocitiesofcontraction
of 90 degrees/second.
2.6. Muscle Structural Characteristics. A needle biopsy was
obtained from the vastus lateralis muscle midway between
the patella and the greater trochanter, at the anterior border
of the iliotibial band. The tissue was frozen in liquid nitrogen
and stored at −80◦C. Frozen 10μm serial cross-sections were
cut by at −20◦Co nam i c r o t o m e .A v e r a g em u s c l eﬁ b e rc r o s s -
sectional area (CSA) was determined by plainmetry from
tissue sections with the basal lamina stained by immuno-
cytochemistry (Developmental Studies Hybridoma Bank,
Iowa City, Iowa, USA). CSA for type I and type II muscle
ﬁbers was then determined by planimetry from tissue cross-
sections that had been incubated with mouse anti-F59 mon-
oclonalantibodyagainsttypeIImyosin(2E8,Developmental
Studies Hybridoma Bank, Iowa city, Iowa, USA) as described
previously [17, 18]. Apoptotic nuclei were identiﬁed by
ﬁrst labeling the tissue sections with ﬂuorescein isothio-
cyanate (FITC) followed by labeling with terminal dUTP
nick-end labeling (TUNEL) (11684795910; Roche Applied
Science, Indianapolis, Ind, USA) and lamina, using methodsCase Reports in Medicine 3
described previously in our lab [19]. The nuclei were
counterstained with 4 ,6-diamidino-2-phenylindole (DAPI).
2.7. Exercise Training. Supervised strength training was
conducted 3 times per week for 16 weeks. The exercises
consisted of using Body Masters machines and free weights.
Theexercises included Monday/Friday: machines—leg press,
bench press, pulldown, triceps extension, and calf raise.
Dumbbell arm curls were performed with free weights.
Wednesday: leg extension, leg curl, and seated rowing were
performed on the weight machines while dumbbell shrug,
dumbbell lateral raises, and dorsi ﬂexion were conducted
with free weights. The training intensity and volume load of
each workout session were recorded in a training log. The
training consisted of three weeks where intensity and load
wereincreasedby5%perweekfollowedbyaoneweekwhere
the volume load was decreased by 5%. A rating of perceived
exertion (RPE) using a 6–20 scale was obtained from the
subject after each exercise session.
2.8. Results. The subject had good compliance to strength
training, as she completed 48 sessions in 16 weeks. There
werenoﬂare-upsofdiseaseactivity,training-relatedinjuries,
or any other adverse events during the 16 weeks of strength
training, and there was no change in medication over the
course of the study.
The physical and body compositional characteristics
of the subject are given in Table 1. The subject’s body
weight and FFM increased by 3.7% and 2.1%, respectively,
afterstrengthtraining.Training-inducedimprovementswere
found in DAS28 (3.39 to 2.00) and pain VAS (40mm to
10mm); REE was 10.4% greater after strength training
as compared to the pretraining level. There was a 12.6%
improvementinthe50-footwalktest(9.54sto8.34s)follow-
ing strength training, but there was no change in 30-second
chair stand test (15 reps) as compared to the pre training
tests. VO2 peak was 8% greater after strength training as
compared to pre training values (1.76 to 1.84,L/min). The
treadmill exercise time to fatigue increased after strength
training (15.30 to 19.30min) as compared to the fatigue
assessment before training (Table 1).
ESR and C-reactive protein were measured as indices of
systemicinﬂammation,butbothmarkerswerewithinnormal
rangesbeforeandafterstrengthtraining(Table 2).C-reactive
protein levels appeared to climb slightly, whereas ESR
decreased after resistance training. Resistance training did
not markedly alter other blood markers for cardiovascular
risk in this subject. However, there was a trend for a slight
increase in blood lipid levels after 16 weeks of exercise
training in this subject.
There were a 13.6% and 9.8% increase in knee extensor
peak torque and power, respectively, and a decrease in work
fatigue from 18.4% before strength training to 15.6% after
strength training (Table 2). Knee ﬂexor peak torque and
average power were 51.9% and 82.5% greater, respectively,
after strength training. Knee ﬂexor work to fatigue decreased
from 27.8% to 13.4% (Table 3).
Table 1: Physical characteristics.
Before training After training
Body weight (kg) 71 73.6
BMI (kg/m2) 27.7 28.7
Fat (%) 29.9 30.9
Fat mass (kg) 21.23 22.74
Fat free mass (kg) 49.8 50.9
REE (kcal/D) 1339 1479
DAS 28 (0–28) 3.39 2
Pain (VAS 0–100mm) 40 10
50 feet walk (s) 9.54 8.34
30 Sec CST (reps) 15 15
VO2peak (L/min) 1.76 1.84
BMI: body mass index; REE: resting energy expenditure; DAS28: disease
activity score; VO2peak: peak oxygen consumption.
Table 2: Blood markers for inﬂammation and lipids.
Before training After training
ESR (mm/hr) 2 1
C-reactive protein (mg/dL) 0.038 0.111
Triglycerides (mg/dL) 53 74
Cholesterol (mg/dL) 182 197
HDL (mg/dL) 56 61
LDL (mg/dL) 115 121
VLDL (mg/dL) 11 15
ESR: erythrocyte sedimentation rate; HDL: high-density lipoproteins; LDL:
low-density lipoproteins; VLDL: very-low density lipoproteins.
Table 3: Muscle performance.
Before training After training
Extension Flexion Extension Flexion
Peak torque (Nm) 116.7 28.4 132.8 43.2
Peak torque/BW (%) 55.1 13.4 62.8 20.4
Work/BW (%) 54.0 14.0 64.0 22.5
Work fatigue (%) 18.4 27.8 15.6 13.4
Average power (Watts) 113.0 24.0 124.1 43.8
BW: body weight; Newton-meters: Nm.
Strength training did not alter ﬁber type distribution
in the vastus lateralis muscle from before training (type
I, 32.6%, type II, 67.4%) to after strength training (type
I, 39.7%; type II, 60.3%). Type I ﬁber CSA was slightly
greater than type II (4997.9μm2 versus 4430.1μm2)b e f o r e
training. The strength-training program increased total ﬁber
CSA by 49.7% (4634.8μm2 versus 6938.6μm2). This was the
result of a 64.9% increase in type I ﬁber CSA (4998.0μm2
to 8239.5μm2) and a 37.3% increase in type II ﬁber CSA
(4430.1 to 6082.8μm2). Examples of tissue cross sections are
shown in Figure 1.
Apoptotic nuclei were present (Figure 2), but they
made up a small percentage of the total myonuclei before
strength training (1.9%). Apoptotic nuclei decreased mod-
estly after strength training (1.6%). Average nucleus/ﬁber4 Case Reports in Medicine
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Figure 1: Frozen tissue cross sections incubated with anti-fast myosin heavy chain (F59). Fibers that were stained for FITC (green) were
identiﬁed as type II ﬁbers, and negatively stained ﬁbers were identiﬁed as type I ﬁbers. The basal lamina of each ﬁber was stained (red) with
an anti-laminin antibody. (a) Type I and type II ﬁbers from the vastus lateralis muscle obtained before exercise training. (b) Type I and
type II ﬁbers from the vastus lateralis muscle obtained after 16 weeks of strength training. (c) Quantiﬁcation of the mean ﬁber area from
the vastus lateralis. These data include both type I and type II ﬁbers. The data were obtained before and after strength training. The data
represent mean ± standard deviation of ﬁber area. (d) Type I and type II ﬁber areas of the vastus lateralis before and after strength training.
CSA increased slightly after strength training (from 0.08 to
0.12 nuclei/μm2).
3. Discussion
In this paper, we show that resistance training improved
walking performance, time to fatigue on a treadmill, and
knee extensor and knee ﬂexor isokinetic power and strength
(torque) in a subject with RA. The improvement in function
could be attributed to the increase in muscle ﬁber cross-
sectional area and the accompanying modest increase in fat-
free mass. Type I ﬁbers appeared to be more responsive to
strength training than type II ﬁbers, in the vastus lateralis of
this subject. Nevertheless, it is important to note that type II
ﬁbers are particularly susceptible to atrophy in rheumatoid
cachexia [5] so, even though this ﬁber type did not enlarge
as much as type I ﬁbers, the type II ﬁber population still
was capable of increasing in size with strength training in
RA. In addition, type II ﬁbers were more abundant in the
vastus lateralis of this subject, so small changes in the size of
this ﬁber type likely translated into important physiological
changes and contributed to greater strength production at
the whole muscle level.
It is not clear if the small decrease in nuclei undergoing
apoptosis(asindicatedbytheTUNELassay)hadasigniﬁcant
role to play in improving muscle mass. However, there
was an increase in nuclear density, suggesting that more
nuclei (presumably satellite cells) were activated as a part
of adaptations to strength training [20]. Nevertheless, even
a very modest decrease in TUNEL-positive nuclei may have
provided a means for accumulating a greater number of
myonuclei. A greater total muscle nuclei population would
have the potential for a greater transcription of mRNA and if
translated, this would result in greater protein accumulation
and muscle mass after resistance training. Nevertheless,
the data indicate that resistance exercise improved muscle
function and mass, and this is consistent with the idea that
rheumatoid cachexia may be able to be reversed or at leastCase Reports in Medicine 5
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Figure 2: Examples of tissue cross-sections. (a) DAPI-stained nuclei. (b) Apoptotic nuclei as indicated by the TUNEL assay. (c) The basal
lamina of ﬁbers was identiﬁed by immunocytochemistry. (d) Overlay of DAPI, TUNEL, and lamina staining. The arrows indicate examples
of apoptotic nuclei.
slowed by an exercise intervention that includes resistance
training, perhaps in part, by protection of activated satellite
cells from apoptosis-induced cell death [9].
Strength training did not increase the symptoms asso-
ciated with RA in the subject studied in this project. In
contrast, the disease activity and pain score were reduced
after 16 weeks of strength training as compared to before
training. However, it is not clear if the reduction in the DAS
index was a direct result of improving muscle structure and
function or if it was the result of other conditions, such as an
exercise-induced mediation of systemic oxidative stress.
Our results are consistent with reported improvements
in exercise-associated elevations in strength and endurance
training in RA patients [21]. Improvement in FFM was
expected, but, in this subject, FM increased along with FFM.
It is possible that the exercise program did not result in a
net caloric deﬁcit, perhaps because the subject increased her
food intake over the course of the study. Alternatively, this
may indicate that resistance training was unable to prevent
the accumulation of body fat, which often accompanies RA
[1, 2]. In fact, persons with RA have a greater likelihood
of obtaining cardiovascular disease [22, 23]. An increase in
total body fat mass, and poor blood lipid proﬁles are risk
factors for cardiovascular disease, and these negative changes
have been implicated in the progression of RA [1, 2]. The
subject examined in the present study had a trend towards
greater adiposity (increased FM) and a trend towards slight
increases in the lipid proﬁle for triglycerides and cholesterol
after 16 weeks of exercise intervention. This suggests that
resistance training was unable to lower cardiovascular risk as
indicated by blood lipid proﬁle, and this may be indicative of
a potential progression towards metabolic syndrome.
It has been proposed that there may be a link between
increased adiposity/metabolic syndrome [24] and cardiovas-
cular disease [25, 26] in RA patients, perhaps triggered by
elevated oxidative stress or inﬂammation. An elevation in
systemic inﬂammation as indicated by increased C-reactive
proteinlevelshasbeenfrequentlynotedinRA[27].However,6 Case Reports in Medicine
this is not a universal observation because recent data
suggest that, for some RA patients, C-reactive protein may
be inactive (<1mg/dL), yet radiographic progression and
joint swelling may be evident [28]. In addition, some RA
patients with high body fat and metabolic syndrome do not
have elevations in C-reactive protein levels [26], a systemic
marker for inﬂammation. Nevertheless, if we assume that
in most cases C-reactive protein is a highly sensitive marker
for inﬂammation, then increases in this marker could point
towards progression of the disease. C-reactive protein levels
were quite low before exercise training in the subject that is
described in this study, and therefore she may ﬁt in with the
groupofpatientswhereC-reactiveproteinisalessresponsive
indicator of RA [26]. Nevertheless, it was interesting to note
that resistance training did not improve this marker and may
have even pushed it to slightly higher levels. Several possibil-
ities could explain this ﬁnding. For example, it is potentially
possible that resistance training resulted in a slight increase
insystemicinﬂammationandacorrespondingslightincrease
inC-reactiveprotein.However,ifthatwasthecase,wewould
also have expected ESR to increase after 16 weeks of exercise
training, but it did not. An alternative explanation is that
the progression of elevated adiposity (due to diet or disease
progression)mighthavecontributedtotheslightlyhigherC-
reactive protein levels. In either scenario, in this study, we
are unable to rule out that resistance training alone might
contribute to, and/or fails to prevent, elevated cardiovascular
risk in persons with RA.
It is likely that if exercise training had involved a
combination of resistance and endurance types of exercise,
then the lipid proﬁle along with C-reactive protein may have
improved. While adding an aerobic component to the exer-
cise program may have reduced FM, and perhaps increased
VO2 peak more than strength training alone, it is not known
if combining strength and endurance exercise would be ben-
eﬁcial for reducing rheumatoid cachexia, muscle function,
and measures of pain in RA as compared with strength
training alone.
Although RA has been associated with muscle loss, the
data in this case study suggest that improvements in isoki-
netic strength and muscle hypertrophy are possible in a sub-
ject with RA. Our data suggest that proper exercise training
that includes strength training may help to reverse or reduce
muscle loss in RA patients. Muscle apoptotic signaling does
not increase with strength training in RA subjects, and
therefore exercise appears to provide therapeutic anabolic
eﬀect for muscles of RA patients. Rather, similar to exercise-
induced reductions in apoptotic signaling that have been
shown in experimental animals [9, 17, 29], the data in this
case study suggest that strength training is a safe and maybe
an eﬀective tool for reducing disease activity and pain and
restoring physical function, muscle mass, muscle ﬁber cross-
sectional area, and muscle strength in a patient with stable
RA.Additionalworkisneededtodetermineifaddingaerobic
training to strength training will provide improvements in
systemic inﬂammation and the blood lipid proﬁle, reduce
fat mass, increase muscle function, and reduce rheumatoid
cachexia in a similar fashion or better than that which is seen
with strength training alone.
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